Literature DB >> 16911729

Systemic disease among cases of fatal opioid toxicity.

Shane Darke1, Sharlene Kaye, Johan Duflou.   

Abstract

AIMS: To determine levels of systemic disease among cases of death due to opioid toxicity.
DESIGN: Analysis of coronial cases.
SETTING: Sydney, Australia. CASES: A total of 841 cases of death due to opioid toxicity (1 January 1998-31 December 2002).
FINDINGS: Ventricular hypertrophy was present in 5.9% of cases and severe coronary artery atherosclerosis in 5.7%. Severe coronary pathology was more pronounced among older cases. Pre-existing bronchopneumonia was present in 13.2% of cases. Hepatic pathology was the most common type of pathology, and was far more marked among older cases. Cirrhosis was present in 25.3% of those aged > 44 years. Levels of renal pathology were comparatively low, but were related significantly to increasing age. Systemic disease in more than one organ system was present in 24.4% of cases, and was related to increasing age (44% of those aged > 44 years). The only pathology for which gender was an independent predictor among opioid cases was ventricular hypertrophy, more common in males.
CONCLUSIONS: Systemic disease, most prominently liver disease, is common among fatal opioid toxicity cases, and may be a factor in understanding the dynamics and age demographics of opioid-related death.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16911729     DOI: 10.1111/j.1360-0443.2006.01495.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  18 in total

1.  Quantifying enhanced risk from alcohol and other factors in polysubstance-related deaths.

Authors:  Zheng Dai; Marie A Abate; D Leann Long; Gordon S Smith; Theresa M Halki; James C Kraner; Allen R Mock
Journal:  Forensic Sci Int       Date:  2020-05-31       Impact factor: 2.395

Review 2.  Dependence and addiction during chronic opioid therapy.

Authors:  David N Juurlink; Irfan A Dhalla
Journal:  J Med Toxicol       Date:  2012-12

3.  Opioid prescribing history prior to heroin overdose among commercially insured adults.

Authors:  Pooja Lagisetty; Kun Zhang; Rebecca L Haffajee; Lewei Allison Lin; Jason Goldstick; Rebecca Brownlee; Amy Bohnert; Marc R Larochelle
Journal:  Drug Alcohol Depend       Date:  2020-05-12       Impact factor: 4.492

4.  Evaluation of a Safer Opioid Prescribing Protocol (SOPP) for Patients Being Discharged From a Trauma Service.

Authors:  Janette Baird; Mark Faul; Traci C Green; Jonathan Howland; Charles A Adams; Melinda J Hodne; Nie Bohlen; Michael J Mello
Journal:  J Trauma Nurs       Date:  2019 May/Jun       Impact factor: 1.010

Review 5.  Eligibility of persons who inject drugs for treatment of hepatitis C virus infection.

Authors:  Amber Arain; Geert Robaeys
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

6.  Preoperative evaluation for coronary atherosclerosis with computed tomography angiography in intravenous drug users: an emerging indication in the face of a growing threat.

Authors:  Anand M Prabhakar; Pedro V Staziaki; Richard A P Takx; Brian B Ghoshhajra
Journal:  Int J Cardiovasc Imaging       Date:  2015-07-25       Impact factor: 2.357

7.  Characteristics of veterans receiving buprenorphine vs. methadone for opioid use disorder nationally in the Veterans Health Administration.

Authors:  Ajay Manhapra; Lantie Quinones; Robert Rosenheck
Journal:  Drug Alcohol Depend       Date:  2016-01-13       Impact factor: 4.492

8.  Changes in the characteristics and levels of comorbidity among new patients into methadone maintenance treatment program in British Columbia during its expansion period from 1998-2006.

Authors:  Behnam Sharif; Bohdan Nosyk; Huiying Sun; David C Marsh; Aslam Anis
Journal:  Subst Use Misuse       Date:  2013-06-10       Impact factor: 2.164

9.  Opiate dependence as an independent and interactive risk factor for arterial stiffness and cardiovascular ageing - a longitudinal study in females.

Authors:  Albert Stuart Reece; Gary Kenneth Hulse
Journal:  J Clin Med Res       Date:  2013-08-05

10.  Reduction in arterial stiffness and vascular age by naltrexone-induced interruption of opiate agonism: a cohort study.

Authors:  Albert Stuart Reece; Gary Kenneth Hulse
Journal:  BMJ Open       Date:  2013-03-21       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.